Letter to the EditorGLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts
Section snippets
Acknowledgements
This work was supported by grants from the National Institutes of Health (DK-44523 to S.B.-W.). The authors thank Ms. Sharon Lee for her secretary contribution and Ms. Jennifer Hollister-Lock for her technical support.
References (10)
- et al.
Exendin-4 is a potent agonist and truncated exendin-(9-39)-amide an antagonist at the GLP-1-(7-36)-amide receptor of insulin-secreting β-cells
J. Biol. Chem.
(1993) - et al.
Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis
J. Biol. Chem.
(2003) - et al.
Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus
N. Engl. J. Med.
(1992) - et al.
The glucagon-like peptide
Endocr. Rev.
(1999) - et al.
Identification of glucagon-like peptide 1 actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signalling
Diabetes
(1998)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2005 Elsevier Ireland Ltd. All rights reserved.